Emre Koca - Publications

ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer.

Journal: Breast cancer research and treatment

Published: October 23, 2020

Measuring Ovarian Escape in Premenopausal Estrogen Receptor-Positive Breast Cancer Patients on Ovarian Suppression Therapy.

Journal: The oncologist

Published: July 10, 2020

Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: November 13, 2018

Preclinical IV busulfan dose-finding study to induce reversible myeloablation in a non-human primate model.

Journal: PloS one

Published: April 01, 2018

Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers.

Journal: Transfusion

Published: February 07, 2014